INGN News and Press, Inogen Inc From 01/07/24

2024-01-07 17:18:52 ET More on Akoya Biosciences, Exact Sciences, etc. Guardant Health: Vast Market Opportunity, Challenging Valuation Illumina: The Divestiture Of Grail Could Unlock Significant Shareholder Value Illumina: Conditions Are Met For A Rebound Nan...

2024-01-01 15:15:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-01-01 08:47:05 ET Summary Inogen's price performance has been poor this year, but a closer look at the numbers suggests that the market's negativity may be unwarranted. Management is actively taking steps to address the company's issues. I'm issuing a Buy rating, but sugg...

2023-12-07 10:00:03 ET More on Health Care Select Sector SPDR Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble Health Care Select Sector Fund ETF: Riding The Healthcare Boom For further details see: Organovo, Fort...

2023-11-13 08:49:47 ET More on Inogen Inogen: Gasping After Strategic Choices Drive Steep Sales And Margin Declines (Rating Downgrade) Inogen Q3 2023 Earnings Preview Inogen names Mike Sergesketter interim CFO, reaffirms 2023 annual revenue expectations For f...

Seasoned Leader Brings More than Two Decades of Medical Device Experience and Proven Track Record of Driving Growth and Organizational Transformation Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today...

Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that management will present at the following investor conferences: Stifel 2023 Healthcare Conference on Wednesday, November 15 at 10:20...

2023-11-07 23:08:07 ET Inogen, Inc. (INGN) Q3 2023 Results Conference Call November 07, 2023 05:00 PM ET Company Participants Marissa Bych - IR Gilmartin Group Nabil Shabshab - President and CEO Mike Sergesketter - Interim CFO Conference Call Participants ...

2023-11-07 16:14:59 ET More on Inogen Inogen: Gasping After Strategic Choices Drive Steep Sales And Margin Declines (Rating Downgrade) Inogen Q3 2023 Earnings Preview Inogen names Mike Sergesketter interim CFO, reaffirms 2023 annual revenue expectations Seeki...

Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the quarter ended September 30, 2023. Third Quarter 2023 and Recent Business Highlights Reported total rev...